"This webpage can include promotional content regarding one or several products of Terumo Europe, or some procedures concerning the use or implantation of such products. This webpage is exclusively intended for healthcare professionals and is in no event directed to the general public."

Cookie policy

This site uses cookies to improve your user experience. By using this website, you agree that we can place cookies on your device. For further information, please read our Privacy And Cookies Policy

I accept the terms and conditions
Skip Ribbon Commands
Skip to main content
  • Increased conformability within unique open-cell design1
  • Optimized radial force to reduce thrombosis and neointima hyperplasia1,2
  • Increased flexibility in severe bend situations1
  • Precise deployment with simplified single-operator system3
  • Proven performance in treating patients worldwide with peripheral artery disease (PAD)3,4,5
Read more Read less
Stent materialNitinol alloy
Stent strut thickness0.185 mm
Delivery catheter structureRapid exchange with ergonomic grip
Guidewire compatibility0.035" (0.89 mm)
Minimum sheath size6 Fr / 2.0 mm
Usable length of catheter135 cm

See the difference

Increased flexibility lowers the potential for stent fracture:1

  • Open-cell structure: The continuous spine-free stent is designed to promote optimal blood flow and eliminate high-strain stress zones that can lead to fracture1
  • In the JP-OSPREY clinical trial, 0% incidence of stent fracture per stent at 12 months post-procedure3
  • Optimized radial force to reduce thrombosis and neointima hyperplasia2

Feel the difference

​Responds to a patient’s natural anatomy with increased conformability6:

  • Responsive in-vitro performance even in severe bend situations.1 In comparison to other self-expanding nitinol stents tested, Misago demonstrated high flexibility and durability in rigorous fatigue-testing simulations.
  • No stent fractures recorded during:
    • 40% compression test that simulated the response during thigh contraction
    • 90° torsion test that simulated the rotation between supine and fetal position
  • More flexible stents may be associated with improved patency7
  • Precision deployment with 100% delivery success3
    • Minimizes jumping, recoil or foreshortening with an easy-to-use thumbwheel system that allows for single operator deployment
    • Enables exact stent placement with the pushability of a triaxial catheter design

Make a difference

​Realize meaningful long-term outcomes in superficial femoral and popliteal arteries.8

Clinically proven results in difficult to treat lesions:

  • In long calcified lesions (> 8 cm)9
    90.3% Primary patency rate at 1 year
  • In popliteal lesions (p1-p3)10
    91.5% Primary patency rate at 1 year

Stent
diameter ​
Stent length (mm) ​ ​ ​ ​ ​
406080100120150
5 mmSX-VXA0540LNSX-VXA0560LNSX-VXA0580LNSX-VXA05X0LN
6 mmSX-VXA0640LNSX-VXA0660LNSX-VXA0680LNSX-VXA06X0LNSX-VXA06X2LNSX-VXA06X5LN
7 mmSX-VXA0740LNSX-VXA0760LNSX-VXA0780LNSX-VXA07X0LNSX-VXA07X2LNSX-VXA07X5LN
8 mmSX-VXA0840LNSX-VXA0860LNSX-VXA0880LNSX-VXA08X0LN
9 mmSX-VXA0940LNSX-VXA0960LN
10 mmSX-VXA1040LNSX-VXA1060LN

 Please quote above item reference codes when placing an order

​This Product is no longer available for sales.

​This Product is no longer available for sales.

You will find here electronic copies of Instructions for Use for selected Terumo products to which European Regulation No. 207/2012 has been applied.

Below you can download the actual Instruction Manual for your product, up to 15 years at least after purchase.

All documents are available to download as PDF files. To read them, you must have Adobe Reader* installed on your computer. If necessary, click here to download Adobe Reader for free.

Please contact Terumo to receive a printed copy of one of the listed e-IFU's within 7 days.

The version of the Instruction Manual that you should refer to depends on what product you received. Please check the Serial Number or lot number of your product to determine the version that goes along with it.

Title Revision number Item reference Revision date Serial number
{{download.Title}} {{download.RevisionNr}} {{download.ItemRef}} {{download.RevisionDate}} {{download.SerialNr}}

 

 

 

 

Comparison of Second-Generation Stents for Application in the Superficial Femoral Artery: An In Vitro Evalution Focusing on Stent Designhttps://www.terumo-europe.com/en-emea/clinical-program/Clinical Data/Comparison of Second-Generation Stents for Application in the Superficial Femoral Artery.pdfComparison of Second-Generation Stents for Application in the Superficial Femoral Artery: An In Vitro Evalution Focusing on Stent Design11/30/2010 11:00:00 PM{E7C8680A-8208-4B36-A279-4AA5C10ACE0B}HayabusaArticleDocument5add21c9-7e01-415f-a533-57956d0e06e2
MISAGO 1: first-in-man clinical trial with Misago nitinol stenthttps://www.terumo-europe.com/en-emea/clinical-program/Clinical Data/MISAGO 1 first-in-man clinical trial with Misago nitinol stent.pdfMISAGO 1: first-in-man clinical trial with Misago nitinol stent4/30/2010 10:00:00 PM{CA3B0011-BE3E-4ADE-9313-FF221CDB6734}HayabusaArticleDocument5add21c9-7e01-415f-a533-57956d0e06e2

 

 

 

 

An Error Occured In Hayabusa SeeAlso: Object reference not set to an instance of an object.

1 Müller-Hülsbeck S, Schäfer PJ, Charalambous N, et al. Comparison of Second-Generation Stents for Application in the Superficial Femoral Artery: An In Vitro Evaluation Focusing on Stent Design. J Endovasc Ther. 2010;17(6):767-776.
2 Deloose K, et al. TVR Reduction in the SFA. EVTODAY. October, 2014;44-47.
3 Presented by Dr Yokoi at TCT 2014.
4 Presented by Dr Ruef at CIRSE 2014.
5 Presented by Dr Müller-Hülsbeck at CIRSE 2014.
6 Compared to six other stents with regard to the appearance of fracture. Müller-Hülsbeck S, Schäfer PJ, Charalambous N, et al. Comparison of Second-Generation Stents for Application in the Superficial Femoral Artery: An In Vitro Evaluation Focusing on Stent Design. J Endovasc Ther. 2010;17(6):767-776.
7 Smouse, R. Achieving Long Term SFA Treatment Success: Stent Design or Patient Selection. International Symposium on Endovascular Therapy, January 2014.
8 I. Kralj et al. Vasa, 2012; 42:313.
9 Results from e-Misago registry - n = 434.
10 Results from e-Misago registry - n = 329.

Did you not find the product you were looking for?